Search for: "Kenneth L. Davis" Results 1 - 20 of 138
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
25 Aug 2023, 6:22 pm by admin
We are 30-plus years into the “Daubert” era, in which federal district courts are charged with gatekeeping the relevance and reliability of scientific evidence. [read post]
3 Mar 2023, 1:22 pm by Jacob Wirz
Section 553 of the Administrative Procedure Act, more commonly known as the notice-and-comment rulemaking process, is hailed as “one of the greatest innovations of modern government. [read post]
10 Feb 2023, 4:44 am by admin
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
28 Jun 2022, 5:58 am by Bernard Bell
” 3 KENNETH DAVIS, ADMINISTRATIVE LAW TREATISE, § 20.04 at 74 (1958); accord, Thunder Basin Coal Co. v. [read post]
16 Apr 2022, 7:40 am by Christopher J. Walker
Cudahy*Professor Kenneth Culp Davis*The Honorable Neil EisnerThe Honorable Russell Frisby Jr.The Honorable Merrick B. [read post]
6 Feb 2022, 9:01 pm by Jonan Pilet
Sponsored by: 3M Food Safety. 2021 Recipient: Armitra Jackson-Davis Ewen C.D. [read post]
5 Oct 2021, 8:21 am
Professor of Law & Director of Clinical Legal Education, UC Davis School of Law--Robert Cover as Critical Race Theorist   Mark Graber, University System of Maryland Regents Professor, University of Maryland Carey School of Law & Sandford V. [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]